Macrophage Activation Status Rather than Repolarization Is Associated with Enhanced Checkpoint Activity in Combination with PI3Kγ Inhibition
| Autor: | Yanjun Wang, Sigourney Bell, A. Hughes, Theresa Proia, Neha Wali, Pablo Morentin Gutierrez, Matthew A. King, Larissa S. Carnevalli, Molly A. Taylor, Danielle Carroll, Michele Moschetta, Maneesh Singh, Antonio Ramos-Montoya, Cristina Gardelli, Stephen Fawell, Simon T. Barry, Anna M. L. Coenen-Stass, Teresa Klinowska, Susan E. Critchlow |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Cancer Research
Tumor microenvironment biology Chemistry Macrophages Dendritic cell Immune checkpoint Disease Models Animal Mice Immune system Oncology Cancer research biology.protein Cytotoxic T cell Macrophage Animals Class Ib Phosphatidylinositol 3-Kinase Humans Female Antibody Immune Checkpoint Inhibitors CD8 |
| Zdroj: | Molecular cancer therapeutics. 20(6) |
| ISSN: | 1538-8514 |
| Popis: | Suppressive myeloid cells mediate resistance to immune checkpoint blockade. PI3Kγ inhibition can target suppressive macrophages, and enhance efficacy of immune checkpoint inhibitors. However, how PI3Kγ inhibitors function in different tumor microenvironments (TME) to activate specific immune cells is underexplored. The effect of the novel PI3Kγ inhibitor AZD3458 was assessed in preclinical models. AZD3458 enhanced antitumor activity of immune checkpoint inhibitors in 4T1, CT26, and MC38 syngeneic models, increasing CD8+ T-cell activation status. Immune and TME biomarker analysis of MC38 tumors revealed that AZD3458 monotherapy or combination treatment did not repolarize the phenotype of tumor-associated macrophage cells but induced gene signatures associated with LPS and type II INF activation. The activation biomarkers were present across tumor macrophages that appear phenotypically heterogenous. AZD3458 alone or in combination with PD-1–blocking antibodies promoted an increase in antigen-presenting (MHCII+) and cytotoxic (iNOS+)-activated macrophages, as well as dendritic cell activation. AZD3458 reduced IL-10 secretion and signaling in primary human macrophages and murine tumor-associated macrophages, but did not strongly regulate IL-12 as observed in other studies. Therefore, rather than polarizing tumor macrophages, PI3Kγ inhibition with AZD3458 promotes a cytotoxic switch of macrophages into antigen-presenting activated macrophages, resulting in CD8 T-cell–mediated antitumor activity with immune checkpoint inhibitors associated with tumor and peripheral immune activation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|